Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

First-Time OTC Facility Inspections Drove US FDA Warning Letter Surge In FY 2019

Nov 06 2019

• By Joanne S. Eglovitch

Related Content

FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

May 07 2007

Warning Letters Mount As FDA Completes Initial Inspections Of Under-The-Radar Facilities

Jun 11 2018

FDA Warning Letters Hit Three Repackers For Failing To Identify Original API Makers

Jul 03 2019

Additional Topics

International United States OTC Drugs FDA Regulation Commercial Compliance Enforcement Manufacturing Policy Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window